Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluating the Safety Profile of Glucagon-Like Peptide-1 Receptor Agonists: Adverse Events and Clinical Recommendations.

Journal of obesity & metabolic syndrome·2026

Same author

Comparison of Efficacy and Safety of Cilostazol/Extract of Ginkgo biloba vs. Aspirin in Carotid Atherosclerosis in Patients with Diabetes Mellitus.

Diabetes & metabolism journal·2025

Same author

Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial.

Diabetes, obesity & metabolism·2025

Same author

Identifying dietary patterns related to metabolic syndrome using the 7th Korea National Health and Nutrition Examination Survey.

The British journal of nutrition·2025

Same author

Characteristics and Treatment Patterns of Patients with Haemophilia B Receiving Recombinant Coagulation Factor IX.

Journal of clinical medicine·2025

Same author

Temporal dynamics of patient complaints in new hospitals: a dynamic time warping and impulse response function analysis of the South Korean healthcare system.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2025

Search research articles

Related Experiment Video

Updated: May 21, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Comorbidity study on type 2 diabetes mellitus using data mining.

Hye Soon Kim¹, A Mi Shin, Mi Kyung Kim

¹Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.

The Korean Journal of Internal Medicine

|June 19, 2012

Summary

This summary is machine-generated.

Essential hypertension is a key comorbidity linked to type 2 diabetes mellitus (T2DM). This study highlights its role in connecting T2DM with stroke and dyslipidemia, using a novel data analysis tool.

Keywords:

Comorbidity Data mining Diabetes mellitus, type 2

Related Experiment Videos

Last Updated: May 21, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Area of Science:

Medical Informatics
Clinical Epidemiology
Data Mining

Background:

Type 2 Diabetes Mellitus (T2DM) is frequently associated with multiple comorbidities.
Understanding these complex interrelationships is crucial for effective patient management.

Purpose of the Study:

To investigate comorbidity patterns in patients with T2DM using Association Rule Mining (ARM).
To identify significant associations between T2DM and other diseases.

Main Methods:

Utilized a large clinical database from Keimyung University Dongsan Medical Center (1996-2007).
Applied the developed Dx Analyze Tool for data cleansing, mart construction, and association rule mining.
Analyzed data from 20,314 T2DM patients out of 411,414 total patients.

Main Results:

Identified 18 significant comorbidity associations meeting predefined support and confidence thresholds.
The strongest association was between T2DM and essential hypertension (support 17.43%, confidence 34.86%).
Essential hypertension emerged as a critical link between T2DM and stroke, and between T2DM and dyslipidemia.

Conclusions:

Essential hypertension significantly influences the association network of T2DM comorbidities.
The Dx Analyze Tool demonstrates practical utility for analyzing large clinical datasets in comorbidity research.